Ryl Tea Secures $20 Million in Latest Series C Funding Round

Ryl Tea secured $20 million in its latest Series C, adding another data point to the Healthcare & Life Sciences funding market.

Ryl Tea Raises $20 million in Funding

Ryl Tea is a Digital Health company focused on expand distribution and capitalize on the growing "Modern Tea" market.

Investors Behind the Funding

The round was backed by Purchase Capital**. Funding Intelligence tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Ryl Tea operates in Healthcare & Life Sciences. Ryl Tea's Series C round shows investors are still backing digital health platforms with real scale narratives. At $20M, the deal suggests buyers want category leaders that can turn AI, automation, or workflow leverage into durable enterprise demand.

Strategic Use of Funds

expand distribution and capitalize on the growing "Modern Tea" market

Looking Ahead

market. The funding will help the company scale operations and attract new consumers. The company aims to lead the emerging

Source reference: original announcement/article.